Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for …
Objectives: This study sought to compare paclitaxel-eluting balloon (PEB) with conventional
percutaneous transluminal angioplasty (PTA), followed by systematic implantation of a self …
percutaneous transluminal angioplasty (PTA), followed by systematic implantation of a self …
Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions: five-year outcomes from the IN. PACT SFA randomized trial
JA Laird, PA Schneider, MR Jaff… - Circulation …, 2019 - Am Heart Assoc
Background: While randomized trials have demonstrated the superiority of drug-coated
balloon (DCB) angioplasty versus standard percutaneous transluminal angioplasty (PTA) in …
balloon (DCB) angioplasty versus standard percutaneous transluminal angioplasty (PTA) in …
ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial
I Ott, S Cassese, P Groha, B Steppich… - Journal of the …, 2017 - Am Heart Assoc
Background Paclitaxel‐eluting balloon (PEB) angioplasty has superior efficacy compared
with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery …
with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery …
Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA
JR Laird, PA Schneider, G Tepe, M Brodmann… - Journal of the American …, 2015 - jacc.org
Background: Evidence from large, randomized, controlled peripheral artery disease trials
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN. PACT SFA randomized trial
PA Schneider, JR Laird, G Tepe… - Circulation …, 2018 - Am Heart Assoc
Background—Randomized controlled trials have reported favorable 1-year outcomes with
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
Drug‐coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal …
O Iida, Y Soga, K Urasawa, S Saito… - Catheterization and …, 2019 - Wiley Online Library
Objectives To assess the longer‐term safety and efficacy of the IN. PACT Admiral (MDT‐
2113) drug‐coated balloon (DCB) for the treatment of de novo and non‐stented restenotic …
2113) drug‐coated balloon (DCB) for the treatment of de novo and non‐stented restenotic …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment
S Steiner, A Willfort-Ehringer, H Sievert, V Geist… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The authors sought to evaluate the performance of the Ranger paclitaxel-coated
balloon versus uncoated balloon angioplasty for femoropopliteal lesions at 12 months …
balloon versus uncoated balloon angioplasty for femoropopliteal lesions at 12 months …
Low-dose paclitaxel–coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the …
H Schroeder, M Werner, DR Meyer, P Reimer… - Circulation, 2017 - Am Heart Assoc
Background: Numerous studies have reported favorable outcomes using drug-coated
balloons (DCBs) for treatment of symptomatic peripheral artery disease of the superficial …
balloons (DCBs) for treatment of symptomatic peripheral artery disease of the superficial …
Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal …
O Iida, Y Soga, K Urasawa, S Saito… - Journal of …, 2018 - journals.sagepub.com
Purpose: To assess the safety and effectiveness of the MDT-2113 (IN. PACT Admiral) drug-
coated balloon (DCB) for the treatment of de novo and native artery restenotic lesions in the …
coated balloon (DCB) for the treatment of de novo and native artery restenotic lesions in the …